ENCHEV/Turk J Chem
31 P NMR (250 MHz, CDCl3) ppm: 27.9; Anal., Calcd. for C16 H24 O2 NPTe (Mr = 420.922): P 7.36, N 3.32;
Found P 7.33, N 3.29 (*Additional signals for diastereomers); 5c, cryst. colorless needles; 1.81 g (81%), mp
◦ C (155–157); IR (KBr) νmax /cm−1 2980, 2677, 1588, 1225, 1000 cm−1 1 H NMR (250 MHz, CDCl3) ppm:
;
7.86–7.87 (m, 2H), 7.30–7.51 (m, 3H), 5.87 (d, JHP 23.5 Hz, 1H), 1.68 (m, 10H), 0.98 (t, JHH 7.0 Hz, 3H),
2.92 (m, JHP 12.4 Hz, 2H). 31 P NMR (250 MHz, CDCl3) ppm: 32.3; Anal., Calcd. for C18 H26 O2 NPTe (Mr
= 446.958): P 6.93, N 3.13; Found P 6.90, N 3.10.
6a, cryst. colorless needles; 1.89 g (87%), mp ◦ C (147–149); IR (KBr) νmax /cm−1 2980, 2677, 1580,
1230, 1000 cm−1 1 H NMR (250 MHz, CDCl3) ppm: 7.86–7.87 (m, 2H), 7.30–7.51 (m, 3H), 6.08 (d, JHP 24.2
;
Hz, 1H), 1.40 (s, 3H), 1.58 (s, 3H), 1.24 (ss, 6H), 2.93 (m, 1H). 31 P NMR (250 MHz, CDCl3) ppm: 28.3; Anal.,
Calcd. for C17 H26 O2 NPTe (Mr = 434.948): P 7.12, N 3.22; Found P 7.10, N 3.19; 6b, cryst. colorless needles;
1.66 g (74%), mp ◦ C (147–149); IR (KBr) νmax /cm−1 2980, 2677, 1597, 1235, 900 cm−1 1 H NMR (250 MHz,
;
CDCl3) ppm: 7.86–7.87 (m, 2H), 7.30–7.51 (m, 3H), 6.55, 6.59* (d, JHP 26.0 Hz, 1H), 1.51, 154* (s, 3H), 1.89
(m, 2H), 0.92 (t, 3H), 1.24 (ss, 6H), 2.93 (m, 1H). 31 P NMR (250 MHz, CDCl3) ppm: 28.3; Anal., Calcd. for
C18 H28 O2 NPTe (Mr = 450.974): P 6.89, N 3.12; Found P 6.86, N 3.10; 6c, cryst. colorless needles; 1.99 g
(84%), mp ◦ C (147–149); IR (KBr) νmax /cm−1 2980, 2677, 1590, 1228, 1004 cm−1
;
1 H NMR (250 MHz,
CDCl3) ppm: 7.86–7.87 (m, 2H), 7.30–7.51 (m, 3H), 5.87 (d, JHP 23.5 Hz, 1H), 1.68 (m, 10H), 1.24 (s, 6H),
2.93 (m, 1H); 31 P NMR (250 MHz, CDCl3) ppm: 28.3; Anal., Calcd. for C20 H30 O2 NPTe (Mr = 475.01): P
6.52, N 2.95; Found P 6.50, N 2.91.
2.4. Synthesis of (5-alkyl-5-alkyl-2-oxo-4-phenyltellanyl-2,5-dihydro-2λ5 -[1,2]-oxaphosphol-2-yl)
alkylamines 8a,b and of alkyl-(2-oxo-4-phenyltellanyl-1-oxa-2λ5 phospha-spiro[4,5]-dec-3-ene
2-yl)amine 8c
2.4.1. General procedure
To a solution of 7 (5 mmol) in methylene chloride (10 mL) was added a solution of phenyltelluryl chloride
(1.24 g, 5.2 mmol) in 5 mL of the same solvent under stirring and cooling (–10 to –12 ◦ C). After 1 h of
stirring at the same conditions, the reaction mixture stood overnight, and was concentrated and recrystallized
in heptane/benzene (2:1).
8a, cryst. colorless needles; 1.61 g (82%), mp ◦ C (147–149); IR (KBr) νmax /cm−1 2980, 2677, 1580,
1245, 1004 cm−1 1 H NMR (250 MHz, CDCl3) ppm: 7.56–7.46 (m, 2H); 7.29–7.23 (m, 3H); 5.35 (d, JHP
;
27.75 Hz, 1H); 2.54 (m, 2H); 1.46 (s, 3H); 1.51 (s, 3H); 2.00 (d, JHP 10.00 Hz, 1H); 1.28–1.19 (m, 2H); 0.91 (t,
3H); 31 P NMR (250 MHz, CDCl3) ppm: 29.0; Anal., Calcd. for C14 H20 O2 NPTe (Mr = 392.87): P 7.88, N
3.56; Found P 7.83, N 3.51; 8b, cryst. colorless needles; 1.52 g (75%), mp ◦ C (147–149); IR (KBr) νmax /cm−1
2980, 2677, 1589, 1230, 960 cm−1 1 H NMR (250 MHz, CDCl3) ppm: 7.86–7.87 (m, 2H), 7.30–7.51 (m, 3H),
;
6.55, 6.59* (d, JHP 26.0 Hz, 1H), 1.51, 154* (s, 3H), 1.89 (m, 2H), 0.92 (t, 3H), 2.54 (m, 2H), 2.00 (d, JHP
10.00 Hz, 1H); 1.28–1.19 (m, 2H); 0.91 (t, 3H). 31 P NMR (250 MHz, CDCl3) ppm: 28.3; Anal., Calcd. for
C15 H22 O2 NPTe (Mr = 406.896): P 7.61, N 3.44; Found P 7.58, N 3.40 (*Additional signals for diastereomers);
8c, cryst. colorless needles; 1.71 g (79%), mp ◦ C (147–149); IR (KBr) νmax /cm−1 2980, 2677, 1587, 1253,
1004 cm−1
;
1 H NMR (250 MHz, CDCl3) ppm: 7.86–7.87 (m, 2H), 7.30–7.51 (m, 3H), 5.87 (d, JHP 23.5 Hz,
1H), 1.68 (m, 10H), 2.54 (m, 2H), 2.00 (d, JHP 10.00 Hz, 1H); 1.28–1.19 (m, 2H); 0.91 (t, 3H); 31 P NMR (250
432